Asarfi Hospital (ASARFI) | Financial Analysis & Statements
Asarfi Hospital Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
356.8M
Gross Profit
271.1M
75.97%
Operating Income
40.0M
11.21%
Net Income
31.2M
8.75%
EPS (Diluted)
₹1.59
Balance Sheet Metrics
Total Assets
1.7B
Total Liabilities
822.7M
Shareholders Equity
841.0M
Debt to Equity
0.98
Cash Flow Metrics
Operating Cash Flow
-93.1M
Free Cash Flow
-106.8M
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Asarfi Hospital Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.2B | 844.0M | 707.0M | 652.1M | 541.2M |
| Cost of Goods Sold | 299.0M | 203.2M | 200.3M | 256.8M | 226.8M |
| Gross Profit | 906.7M | 640.8M | 506.7M | 395.4M | 314.4M |
| Gross Margin % | 75.2% | 75.9% | 71.7% | 60.6% | 58.1% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 270.2M | 178.8M | 130.2M | 104.4M | 81.6M |
| Other Operating Expenses | 189.8M | 339.0M | 125.7M | 93.8M | 68.6M |
| Total Operating Expenses | 460.0M | 517.8M | 255.9M | 198.2M | 150.2M |
| Operating Income | 124.3M | 72.6M | 99.0M | 74.4M | 52.8M |
| Operating Margin % | 10.3% | 8.6% | 14.0% | 11.4% | 9.8% |
| Non-Operating Items | |||||
| Interest Income | 12.1M | 7.0M | 2.2M | 2.9M | 1.7M |
| Interest Expense | 40.4M | 26.9M | 8.7M | 2.3M | 4.7M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 143.1M | 62.4M | 108.9M | 77.2M | 47.7M |
| Income Tax | 37.3M | 20.8M | 28.7M | 19.9M | 12.4M |
| Effective Tax Rate % | 26.1% | 33.3% | 26.4% | 25.8% | 26.0% |
| Net Income | 105.8M | 41.6M | 80.2M | 57.3M | 35.3M |
| Net Margin % | 8.8% | 4.9% | 11.3% | 8.8% | 6.5% |
| Key Metrics | |||||
| EBITDA | 289.5M | 177.2M | 156.3M | 112.9M | 83.1M |
| EPS (Basic) | ₹5.37 | ₹2.31 | ₹4.07 | ₹2.91 | ₹1.80 |
| EPS (Diluted) | ₹5.37 | ₹2.31 | ₹4.07 | ₹2.91 | ₹1.80 |
| Basic Shares Outstanding | 19677300 | 18015584 | 19677300 | 19677300 | 19677300 |
| Diluted Shares Outstanding | 19677300 | 18015584 | 19677300 | 19677300 | 19677300 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Asarfi Hospital Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 14.3M | 176.0M | 85.2M | 137.2M | 67.5M |
| Short-term Investments | 139.7M | - | - | - | - |
| Accounts Receivable | 398.0M | 242.6M | 169.3M | 53.3M | 21.0M |
| Inventory | 22.8M | 18.0M | 14.2M | 10.9M | 8.2M |
| Other Current Assets | 141.1M | - | - | - | - |
| Total Current Assets | 584.8M | 467.5M | 365.1M | 220.8M | 96.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 168.0K | 0 | 0 | 0 | 0 |
| Goodwill | - | - | 0 | 0 | 0 |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 16.4M | -1.0K | -1.0K | -1.0K | -1.0K |
| Total Non-Current Assets | 1.1B | 1.1B | 569.2M | 406.2M | 276.1M |
| Total Assets | 1.6B | 1.5B | 934.3M | 627.0M | 372.9M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 130.4M | 248.6M | 49.9M | 24.0M | 14.1M |
| Short-term Debt | 147.3M | 115.9M | 64.1M | 56.5M | 46.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 76.7M | - | 1.0K | 1.0K | - |
| Total Current Liabilities | 410.4M | 414.8M | 195.9M | 147.6M | 86.3M |
| Non-Current Liabilities | |||||
| Long-term Debt | 338.3M | 203.2M | 107.9M | 59.9M | 25.0M |
| Deferred Tax Liabilities | 33.7M | 27.2M | 8.1M | 7.2M | 7.5M |
| Other Non-Current Liabilities | 1.0M | - | -1.0K | -1.0K | - |
| Total Non-Current Liabilities | 418.6M | 422.0M | 319.9M | 253.1M | 117.6M |
| Total Liabilities | 829.0M | 836.8M | 515.8M | 400.8M | 204.0M |
| Equity | |||||
| Common Stock | 196.8M | 196.8M | 145.0M | 12.5M | 12.5M |
| Retained Earnings | 353.7M | 247.9M | 193.3M | 175.6M | 118.4M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 809.8M | 704.1M | 418.4M | 226.3M | 169.0M |
| Key Metrics | |||||
| Total Debt | 485.6M | 319.1M | 172.0M | 116.3M | 71.3M |
| Working Capital | 174.5M | 52.7M | 169.2M | 73.2M | 10.5M |
Balance Sheet Composition
Asarfi Hospital Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 105.8M | 41.6M | 108.9M | 77.2M | 47.7M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -181.7M | -101.2M | -200.2M | -13.3M | 37.5M |
| Operating Cash Flow | -76.5M | -39.7M | -80.1M | 67.9M | 89.9M |
| Investing Activities | |||||
| Capital Expenditures | -105.0M | -460.7M | -201.4M | -195.2M | -83.6M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | 0 | -96.9M | 0 | -71.0M | -43.9M |
| Investment Sales | 18.3M | 0 | 63.1M | 0 | 0 |
| Investing Cash Flow | -85.9M | -562.5M | -138.4M | -266.1M | -127.5M |
| Financing Activities | |||||
| Share Repurchases | 0 | 0 | -62.5M | 0 | 0 |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 220.4M | 116.8M | - | - | - |
| Debt Repayment | -55.3M | -21.4M | - | - | - |
| Financing Cash Flow | 158.0M | 391.0M | 112.0M | 0 | 0 |
| Free Cash Flow | -161.4M | -200.0M | -222.1M | -102.5M | 19.3M |
| Net Change in Cash | -4.4M | -211.2M | -106.5M | -198.2M | -37.6M |
Cash Flow Trend
Asarfi Hospital Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
25.14
Price to Book
4.37
Price to Sales
2.55
PEG Ratio
0.24
Profitability Ratios
Profit Margin
10.17%
Operating Margin
15.67%
Return on Equity
19.09%
Return on Assets
6.78%
Financial Health
Current Ratio
1.40
Debt to Equity
58.07
Beta
-0.92
Per Share Data
EPS (TTM)
₹8.29
Book Value per Share
₹47.69
Revenue per Share
₹81.65
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ASARFI | 4.1B | 25.14 | 4.37 | 19.09% | 10.17% | 58.07 |
| Apollo Hospitals | 1.1T | 61.08 | 12.11 | 16.71% | 7.44% | 83.61 |
| Max Healthcare | 979.8B | 68.81 | 9.77 | 11.47% | 17.43% | 32.58 |
| Indraprastha Medical | 37.3B | 20.08 | 5.57 | 26.98% | 12.60% | 4.76 |
| Dr. Agarwal's Eye | 24.3B | 34.01 | 7.52 | 26.07% | 15.50% | 106.45 |
| Shalby | 16.7B | 207.28 | 1.75 | 0.63% | 0.72% | 53.32 |
Financial data is updated regularly. All figures are in the company's reporting currency.




